Kezar Life Sciences, Inc. (KZR) Tops Q1 EPS by 5c

Kezar Life Sciences, Inc. (NASDAQ: KZR) reported Q1 EPS of ($0.30), $0.05 better than the analyst estimate of ($0.35).

For earnings history and earnings-related data on Kezar Life Sciences, Inc. (KZR) click here.

You May Also Be Interested In

• KB Home (KBH) Tops Q3 EPS by 16c
• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
• Sun Communities completes $1.03B sale of Park Holidays to Aermont